TIMELY is a EU-funded project. It started on January, 1st 2021 and will end in March 2025.
The objective is to develop and implement a platform that provides AI-powered apps and dashboards and decision support tools assisting patients and clinicians to personalize healthcare based on risk evaluation, outcome prediction and tailored interventions.
The platform will be developed based on a functional platform for interoperability with electronic health records and security mechanisms. AI in TIMELY, built with big retrospective datasets of will constantly monitor and evaluate risks and will indicate any deviation from defined therapy goals or unfavorable changes as well as propose proper interventions.
Visit us on Research Gate: tinyurl.com/TIMELYresearchgate
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101017424.
The content reflects only the authors’ views, and the European Commission is not responsible for any use that may be made of the information it contains.
Company Details
- Employees
- 2
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.timely-project.com
Timely Eu Project Questions
Timely Eu Project's website is https://www.timely-project.com
Timely Eu Project's LinkedIn profile is https://www.linkedin.com/company/timely-eu-project
Timely Eu Project has
2 employees.
View email and phone details for 2
employees at Timely Eu Project.
Timely Eu Project's industry is
Research Services
Timely Eu Project's top competitors are
Hybridecho,
Biosignal Group,
Capemed,
Soro Global,
Ecgxfusion,
Biosignal Processing Group,
Infocape Ltd,
Biotronik,
Semdatex Gmbh,
Villa Mondragone.
Timely Eu Project's categories are Research Services
